KLRB1 and glioblastoma: The results revealed that high CD161 expression was observed in 14 tumours: ACC, CESC, ESCA, GBM, KIRC, KIRP, LAML, LGG, OV, PAAD, READ, SKCM, STAD, and TGCT.